Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis
European Journal of Neurology2021Vol. 28(10), pp. 3517–3529
Citations Over TimeTop 1% of 2021 papers
Lina Palaiodimou, Maria‐Ioanna Stefanou, Aristeidis H. Katsanos, Paraskevi C. Fragkou, Μarianna Papadopoulou, Christos Moschovos, Ioannis Michopoulos, Panagiotis Kokotis, Christos Bakirtzis, Androniki Naska, Theodoros I. Vassilakopoulos, Elisabeth Chroni, Sotirios Tsiodras, Georgios Tsivgoulis
Abstract
GBSs prevalence was estimated at 15 cases per 100,000 SARS-CoV-2 infections. COVID-19 appears to be associated with an increased likelihood of GBSs and with demyelinating GBSs variants in particular.
Related Papers
- → Impact of Resident Involvement on Orthopaedic Surgery Outcomes: An Analysis of 30,628 Patients from the American College of Surgeons National Surgical Quality Improvement Program Database(2014)112 cited
- → Obesity, Age, Sex, Diagnosis, and Fixation Mode Differently Affect Early Cup Failure in Total Hip Arthroplasty(2010)58 cited
- → Care fragmentation in hepatopancreatic surgery and postoperative outcomes(2024)15 cited
- → Cardiovascular surgery risk prediction from the patient’s perspective(2011)6 cited
- → Faculty Opinions recommendation of Patient flow variability and unplanned readmissions to an intensive care unit.(2009)